Foxchart.com
Oncolytics Biotech Inc. (ONCY)
1.27  0.03 (2.42%)  10-10 10:07
Open: 1.27
High: 1.3
Low: 1.26
Volume: 117,221
Market Cap: 127(M)
PE Ratio: -4.88
Exchange: NASDAQ Capital Market
Industry: Biotechnology
Sector: Healthcare
Technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell buy
Resistance 2: 1.51
Resistance 1: 1.37
Pivot price: 1.33
Support 1: 1.14
Support 2: 0.95
52w High: 1.51
52w Low: 0.33
Watchlist
ONCY0 (0%)
BWB0 (0%)
DEUR0 (0%)
COKE0 (0%)
FAN0 (0%)
BXS0 (0%)
Zoom in Zoom out
Draw lines
Horizontal lines
Parallel lines
Fibonacci lines
Remove studies
Shot and share

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and avelumab, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer; and PrECOG LLC. The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Financials
EPS -0.270
Book Value 0.060
PEG Ratio 0.00
Gross Profit 0.000
Profit Margin (%) 0.00
Operating Margin (%) 0.00
Return on Assets (ttm) -74.6
Return on Equity (ttm) -249.3
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
×
Share on Facebook Tweet this page

Foxchart international:  |  United States  |  Canada  |  United Kingdom  |  Australia  |  New Zealand  |  Singapore  |  India

©Foxchart.com All Rights Reserved. Foxchart.com | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither Foxchart.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX